menu
    • menu

    Company profile for LTZ Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LTZ Therapeutics is an immunotherapy-focused biotech company pursuing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. LTZ is focused on leveraging the power of innate immunity (e.g., macrophages) and elimination of immunosuppression (e.g., T regulatory cells, cancer-associated fibroblasts) as these areas have been shown to offer tremendous ...
    LTZ Therapeutics is an immunotherapy-focused biotech company pursuing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. LTZ is focused on leveraging the power of innate immunity (e.g., macrophages) and elimination of immunosuppression (e.g., T regulatory cells, cancer-associated fibroblasts) as these areas have been shown to offer tremendous potential for developing innovative and effective therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LTZ TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1100 Island Dr., Suite 103, Redwood City, CA, 94065
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.ltztherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ltz-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GSK Partners LTZ Therapeutics For Advanced Cancer Treatments
    GSK Partners LTZ Therapeutics For Advanced Cancer Treatments

    21 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/rd/gsk-teams-up-with-ltz-therapeutics-to-launch-next-generation-cancer-therapies-18293

    INDPHARMAPOST
    21 Nov 2025
    Share Share
    GSK Pens $50M Pact To Join Big Pharma Peers In Emerging Modality
    GSK Pens $50M Pact To Join Big Pharma Peers In Emerging Modality

    19 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gsk-pens-50m-ltz-pact-join-big-pharma-peers-emerging-modality

    FIERCE BIOTECH
    19 Nov 2025
    Share Share
    LTZ Therapeutics, Eli Lilly Collab on Autoimmune Disease Platform
    LTZ Therapeutics, Eli Lilly Collab on Autoimmune Disease Platform

    29 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250729256494/en/LTZ-Therapeutics-Announces-Strategic-Collaboration-with-Eli-Lilly-to-Advance-Development-of-its-Myeloid-Engager-Platform-for-Autoimmune-Diseases

    BUSINESSWIRE
    29 Jul 2025
    Share Share
    LTZ Gets FDA IND Clearance For LTZ-301 Myeloid Engager Trial
    LTZ Gets FDA IND Clearance For LTZ-301 Myeloid Engager Trial

    24 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250220085305/en

    BUSINESSWIRE
    24 Feb 2025
    Share Share
    LTZ Therapeutics Raises $20M+ Series A For Immunotherapy Pipeline
    LTZ Therapeutics Raises $20M+ Series A For Immunotherapy Pipeline

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730426200/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search